Valuation: Circio Holding ASA

Market Cap 1.89B 193M 168M 153M 144M 271M 18.34B 277M 1.85B 720M 8.99B 723M 707M 30.98B P/E 2024
0.25x
P/E 2025 -2.65x
Enterprise Value 1.89B 193M 168M 154M 144M 271M 18.36B 277M 1.85B 721M 9B 724M 708M 31.02B EV / Sales 2024
-
EV / Sales 2025 -
Free-Float
86.36%
Yield 2024 *
-
Yield 2025 -

Last Transcript: Circio Holding ASA

1 day+4.89%
1 week+4.34%
Current month+7.73%
1 month-5.48%
3 months-26.48%
6 months+550.82%
Current year+582.13%
1 week 7.17
Extreme 7.17
8.17
1 month 6.94
Extreme 6.94
8.77
Current year 0.98
Extreme 0.978
14.46
1 year 0.55
Extreme 0.547
14.46
3 years 0.48
Extreme 0.48
19.62
5 years 0.48
Extreme 0.48
246.3
10 years 0.48
Extreme 0.48
1,017
Manager TitleAgeSince
Chief Executive Officer - 2021-10-19
Director of Finance/CFO 58 2022-03-06
Chief Tech/Sci/R&D Officer - 2021-12-31
Director TitleAgeSince
Director/Board Member 79 2015-06-30
Director/Board Member 66 2015-09-13
Chairman 64 2020-04-28
Date Insider Type Main position Quantity % Market Cap.
21-11-29Fiscal year

Chief Executive Officer

120,000 0.1386%
21-05-18Buy

Director

21,299 0.0246%
20-12-02Buy

Chief Technology Officer

10,000 0.0116%
Change 5-day change 1-year change 3-year change Capi.($)
+4.89%+4.34%+1,166.35%-53.89% 192M
+0.68%+5.92%+77.86%+139.22% 59.1B
+2.32%+5.03%+75.26%+91.40% 55.19B
+3.86%+6.93%-11.32%-9.53% 24.67B
+4.30%+7.95%+14.11%+437.83% 24.19B
+4.74%+13.68%+43.36%-4.67% 19.69B
-0.29%+9.78%+43.90%-28.41% 17.56B
0.00%+20.78%+186.15%+361.42% 16.22B
+6.72%+19.38%+37.85% - 14.84B
+3.50%+1.97%+21.02%+191.95% 14.04B
Average +3.07%+8.14%+165.45%+125.04% 24.57B
Weighted average by Cap. +2.46%+6.47%+59.19%+136.82%

Financials

2024 2025
Net sales - -
Net income 57.52M 5.86M 5.11M 4.67M 4.38M 8.25M 558M 8.42M 56.32M 21.9M 274M 22M 21.53M 943M -45.91M -4.68M -4.08M -3.72M -3.49M -6.58M -445M -6.72M -44.95M -17.48M -218M -17.56M -17.18M -753M
Net Debt -972K -99.06K -86.38K -78.86K -74K -139K -9.43M -142K -952K -370K -4.62M -372K -364K -15.93M 2.24M 229K 200K 182K 171K 322K 21.78M 329K 2.2M 855K 10.68M 859K 840K 36.8M
Logo Circio Holding ASA
Circio Holding ASA, formerly Targovax ASA, is a Norway-based company active within the healthcare sector. The Company is engaged in the biotechnology and develops ribonucleic acid (RNA) and immunotherapy medicines. The Company offers circular RNA (circRNA) platform to develop circRNA medicines for cancer, vaccines, protein replacement for genetic disorders and cell therapy. The circVec technology is based on a modular genetic cassette design for efficient biogenesis of multifunctional circRNA from DNA-based vectors that can be deployed for multiple purposes. Circios strategy is to develop circAde cancer medicines in-house and seek partnerships in other therapeutic areas to demonstrate the broad potential of the circVec platform and accelerate circRNA pipeline development. Circio’s second clinical program is an immunotherapy targeting KRAS driver mutations.
Employees
10
Date Price Change Volume
26-07-03 NOK 7.940 +4.89% 5,609,934
26-07-02 NOK 7.570 +2.16% 3,404,702
26-07-01 NOK 7.410 +0.54% 1,998,140
26-06-30 NOK 7.370 -1.07% 4,280,344
26-06-29 NOK 7.450 -2.10% 3,324,258

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. TRVX Stock